Trademark applications and grants for Eragen Biosciences Inc. Eragen Biosciences Inc has 14 trademark applications. The latest application filed is for "ERACODE"
Patent Application | Date |
---|---|
Materials and methods for the detection of anthrax related toxin genes 20120122095 - 11/652702 Moser; Michael James ;   et al. | 2012-05-17 |
Methods for detection and typing of nucleic acids 20100221702 - 11/447734 Moser; Michael James | 2010-09-02 |
METHODS AND KITS FOR DETECTING JAK2 NUCLEIC ACID 20080153097 - 11/940875 Johnson; Scott C. ;   et al. | 2008-06-26 |
USE OF NON-STANDARD BASES AND PROXIMITY EFFECTS FOR GENE ASSEMBLY AND CONVERSION OF NON-STANDARD BASES TO STANDARD BASES DURING DNA SYNTHESIS 20070264694 - 11/733011 Prudent; James R. | 2007-11-15 |
Nucleic acid amplification using non-standard bases 20070105099 - 10/542464 Prudent; James R. ;   et al. | 2007-05-10 |
NCAGE Code | 1V8J6 | ERAGEN BIOSCIENCES INC. |
CAGE Code | 1V8J6 | ERAGEN BIOSCIENCES, INC. |
DUNS | 130023591 | ERAGEN BIOSCIENCES, INC. |
SEC | 0001097056 | ERAGEN BIOSCIENCES INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.